CMO Corner

ASCO 2024: Promoting “The Art and Science of Cancer Care: From Comfort to Cure”

40,000 in attendance for 200+ exciting oncology presentations, networking and collaborations. In the lead up to the 2024 ASCO annual meeting, oncology professionals were invited to “Come for the science, stay for the connection and leave with an inspiration that will drive you forward.” Aside from the science, this year’s ASCO theme was also focused […]

Read More

June 25th, 2024

FDA Accelerated Approval Gives Hope to Those in Greatest Need

Rare diseases affect 350 million globally, but with few available treatments, time is of the essence. If you or a loved one suffered from a rare disease for which there is no treatment or cure, and there was a drug that had shown potential to give you some relief—some hope—you would want to have access […]

Read More

April 8th, 2024

ASN Kidney Week 2023: Signaling the Onset of a New Golden Age for Kidney Disease Clinical Trials

George Clinical’s global renal team well represented in attendance and presentations. At the opening plenary of Kidney Week 2023, ASN President Michelle A. Josephson acknowledged the contributions that the 12,000 attendees are making in the fight against kidney diseases who are “mounting a daily fight on behalf of your patients—working on matters of existential importance […]

Read More

December 6th, 2023

IgAN Therapies: Can Success Signal New Challenges for Clinical Trials?

Will new treatments decrease potential participants for ongoing and future research? In a world where more efficient and better targeted treatments are being approved at an unprecedented rate, patients are understandably eager to take advantage of the new discoveries, especially when it comes to rare diseases such as Immunoglobulin A nephropathy (IgAN) where safe and […]

Read More

October 23rd, 2023

2023 ASCO Celebrates Patients at the Cornerstone of Cancer Care and Research

Patient-centricity is the key to more successful research and adoption of new treatments. ASCO’s 2023 Annual Meeting drew oncology professionals from around the world to learn about new clinical advances in cancer research, gain real-time insights from world-renowned experts and connect with one of the largest, most diverse audiences in global oncology. Peer-to-peer interaction is the […]

Read More

July 12th, 2023

Emerging Countries Offer Access to Diverse Patient Populations, Cost Savings and the Opportunity to Advance Equity in Clinical Research

Having recently attended the World Congress of Nephrology (WCN) in Bangkok, Thailand, George Clinical representatives had the opportunity to meet experts and peers from around the world to share ideas and best practices and continue to develop networks that will advance global kidney health. Connecting with communities from different parts of the world not only highlights […]

Read More

June 21st, 2023

Biomarkers Will Drive Future Diagnosis and Treatment of Kidney Disease

A deeper understanding of disease mechanisms will help address a growing global problem. Chronic kidney disease (CKD) is a global health crisis with an estimated 850 million people affected worldwide. Rising faster than all non-infectious diseases including cardiovascular disease, CKD is 20 times more prevalent than cancer. Most people don’t even realize their kidneys are […]

Read More

March 24th, 2023

Strengthening Relationships and Extending Partnerships for Early Phase Trials Across the APAC Region

George Clinical Represented at AusBiotech 2022 Conference in Perth. Australia is a world-leading location for the life sciences and has been ranked among the top five in biotechnology innovation for the third consecutive year. AusBiotech is Australia’s life sciences organization, working on behalf of a well-connected network of over 3,000 members for more than 35 […]

Read More

December 1st, 2022

ASCO 2022 Presentations Show Promise for Paradigm Shifts in Cancer Diagnosis and Treatments

That leaves 80% of mBC patients with fewer treatment options. However, research has shown that 55%-60% of these actually express low levels of HER2, and this is the category that Destiny-04 targeted, demonstrating that the legacy cutoff point to determine HER2 positivity can now be extended. These results establish HER2-low metastatic breast cancer as a […]

Read More

August 11th, 2022

2022 ASCO Addresses Disparities in Cancer Care and Research

COVID era innovations will help shape the future for more equitable representation. Oncology professionals from around the world attended the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in June, one of the largest oncology research conferences of the year. Researchers presented breakthrough clinical trial data including new treatment options, symptom management and research […]

Read More

June 21st, 2022

Add George Clinical to your network